Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-5-25
|
pubmed:abstractText |
The influence of colony-stimulating factors (CSFs) on the monocyte functions of 32 patients with refractory testicular cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation (ABMT) was tested. Eight patients were treated as a control group without CSF therapy, 12 patients received recombinant human granulocyte-macrophage-CSF (rhGM-CSF), and 12 patients received recombinant human granulocyte-CSF (rhG-CSF). For the assessment of monocyte activation induced by CSF expression of major histocompatibility complex (MHC) class I and II antigens, production of tumor necrosis factor (TNF) and monocyte-mediated cytotoxicity against tumor cell targets were chosen. Monocytes from patients with GM-CSF therapy showed a significant increase in MHC class I and II antigen expression as compared to patients without CSF treatment (p < 0.001). A significant increase in the expression of MHC class I was seen in monocytes from patients under G-CSF treatment, whereas no change of class II antigens was noticed. Production of TNF and monocyte-mediated cytotoxicity against U937 tumor cells was significantly increased in monocytes derived from patients receiving GM-CSF, as compared to those from the control group, while no effect was detectable in monocytes from patients with G-CSF therapy. However, after in vitro stimulation with interferon-gamma (IFN-gamma), monocytes derived from GM-CSF as well as from G-CSF treated patients responded with a significantly higher TNF-production and cytotoxicity than monocytes from control patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0301-472X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
402-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:7536681-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7536681-Bone Marrow Transplantation,
pubmed-meshheading:7536681-Cells, Cultured,
pubmed-meshheading:7536681-Combined Modality Therapy,
pubmed-meshheading:7536681-Cytotoxicity, Immunologic,
pubmed-meshheading:7536681-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:7536681-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:7536681-HLA Antigens,
pubmed-meshheading:7536681-Humans,
pubmed-meshheading:7536681-Interferon-gamma,
pubmed-meshheading:7536681-Male,
pubmed-meshheading:7536681-Monocytes,
pubmed-meshheading:7536681-Testicular Neoplasms
|
pubmed:year |
1995
|
pubmed:articleTitle |
Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
|
pubmed:affiliation |
Clinical Division of Oncology, University Hospital, Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|